Job Watch

BRAIN Initiative: Brain Behavior Quantification and Synchronization Data Coordination and Artificial Intelligence Center (U24 Clinical Trial Optional)

Funding Opportunity RFA-MH-23-130 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for creating the Data Coordination and Artificial Intelligence Center (DCAIC) for the Brain Behavior Quantification and Synchronization (BBQS) Consortium of the BRAIN Initiative. The FOA will support a single award to a multi-disciplinary team with a single or multiple PIs working on the five interrelated areas:1) Data Management; 2) Data Standards; 3) ML/AI Resources; 4) Data Ecosystem; and 5) Dissemination, Training and Coordination.

BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)

Funding Opportunity RFA-MH-23-110 from the NIH Guide for Grants and Contracts. The purpose of the The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area that is aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and who expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training.

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

Funding Opportunity PAR-23-148 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection in existing cohorts of adult and/or pediatric TB participants to better characterize and understand adverse outcomes and morbidity associated with TB disease post treatment in individuals with and without HIV infection.

Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)

Funding Opportunity RFA-CA-23-023 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to establish collaborations between liver cancer investigators and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded Liver Cirrhosis Network (LCN) members to advance our understanding of hepatocellular carcinoma (HCC) as the result of liver cirrhosis and its etiologic risks, development, progression, early diagnosis, and treatment. The funds available through this FOA will support new multidisciplinary liver cancer-specific collaborations between eligible liver cancer investigators and one or more of the NIDDK-funded LCN members. This structure is intended to maximize the effectiveness of the network by facilitating collaborative opportunities that enhance the scientific goals of the collaborating units and the LCN as a whole. Applicants selected for NCI funding will become members of the Liver Cirrhosis Network-Liver Cancer Collaboratory (LCN-LCa) Committee.

Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional)

Funding Opportunity RFA-OD-23-015 from the NIH Guide for Grants and Contracts. As part of the ADVANCE: Advancing Prevention Research for Health Equity program, the NIH Office of Disease Prevention (ODP) within the Office of the Director Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) is soliciting revision applications (formerly called "competitive revisions") to active R01 grants to support studies that develop and evaluate menthol cigarette smoking cessation and prevention interventions for populations that experience health disparities.

Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)

Funding Opportunity PAR-23-152 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

Funding Opportunity PAR-23-153 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement, the National Cancer Institute (NCI) intends to focus on the impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)

Research Technologist I - Medical College of Wisconsin - Milwaukee, WI

Indeed.com - Bioinformatics - Wed, 2023-03-29 17:08
Other preferred experience may include one or more of the following: care and maintenance of mouse colony, working with mouse models of infectious disease or…
From Medical College of Wisconsin - Wed, 29 Mar 2023 21:08:13 GMT - View all Milwaukee, WI jobs
Categories: Job Watch

EMBL: Jobs at EMBL-EBIDeputy Head of Human Resources, EMBL-EBI

New Scientist - Bioinformatics - Wed, 2023-03-29 13:48
Competitive Salary: EMBL: We are looking for an experienced and exceptional HR professional, with solid experience in developing and implementing career development programmes Hinxton, Cambridgeshire, England
Categories: Job Watch

EMBL: Jobs at EMBL-EBICommunications Officer

New Scientist - Bioinformatics - Wed, 2023-03-29 13:48
Competitive Salary: EMBL: EMBL’s European Bioinformatics Institute (EMBL-EBI) is looking for a Communications Officer to cover a period of maternity leave. This is a rare chanc Hinxton, Cambridgeshire, England
Categories: Job Watch

EMBL: Jobs at EMBL-EBIMGnify Website Developer

New Scientist - Bioinformatics - Wed, 2023-03-29 13:48
Competitive Salary: EMBL: MGnify is EMBL-EBI’s microbiome sequence data analysis resource, which performs the archiving, assembly and analysis of metagenomics data. As the nu Hinxton, Cambridgeshire, England
Categories: Job Watch

SRG: Data Quality Partner - 17988453

New Scientist - Bioinformatics - Wed, 2023-03-29 04:38
GBP0.00 - GBP17 per hour: SRG: - Berkshire, England
Categories: Job Watch

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

Funding Opportunity PAR-23-132 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support research that addresses research questions relevant to human dental, oral, or craniofacial (DOC) diseases and conditions through analysis of existing and publicly available genomics data using data science approaches.

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Funding Opportunity PAR-23-133 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support research that addresses research questions relevant to human dental, oral, or craniofacial (DOC) diseases and conditions through analysis of existing and publicly available genomics data using data science approaches.

Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-23-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research focused on the development of convenient small animal models that will support infection and replication of HBV and/or HCV, ideally leading to the dichotomous outcomes of clearance and persistence. Alternatively, closely related surrogate virus-host systems or robust xenotransplantation models dually engrafted with human liver cells and human immune systems can be developed.

Pages

Subscribe to Anil Jegga aggregator - Job Watch